No Data
No Data
180 Life Sciences Has Received A Notice Of Allowance For A U.S. Patent Titled "METHOD OF TREATING EARLY STAGE DUPUYTREN'S DISEASE".
Express News | 180 Life Sciences Has Received A Notice Of Allowance For A U.S. Patent Titled "METHOD OF TREATING EARLY STAGE DUPUYTREN'S DISEASE"
Express News | Blair Jordan Reports 10.5% Stake in 180 Life Sciences Corp as of Feb 20 - SEC Filing
180 Life Sciences Appoints New CEO Amid Leadership Changes
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
180 Life Sciences Announces Key Proposals and Director Elections